Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor nucleosides disclosed by Yamasa Shoyu

May 3, 1996

GBC590 progresses to toxicity testing

April 26, 1996

Taisho isolates FD-594 from Streptoverticillium

April 26, 1996

Repligen terminates rPF4 development agreement

April 26, 1996

Antiandrogen research at Roussel Uclaf

April 26, 1996

Topotecan approval recommended

April 26, 1996

MitoExtra enters clinical trials

April 26, 1996

Glaxo Wellcome/BioChem Pharma antitumor agent described at 211th ACS

April 19, 1996

Photofrin approved for marketing in France

April 19, 1996

NU-1064 and NU-1076, PARP inhibitors

April 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...